Do CARs need a driver's license? Adoptive cell therapy with chimeric antigen receptor-redirected T cells has caused serious adverse events.
Affiliation
Zentrum für Molekulare Medizin Köln and Klinik I für Innere Medizin, Uniklinik Köln, Cologne, Germany.Issue Date
2010-09
Metadata
Show full item recordCitation
Do CARs need a driver's license? Adoptive cell therapy with chimeric antigen receptor-redirected T cells has caused serious adverse events. 2010, 21 (9):1039-42 Hum Gene TherJournal
Human Gene TherapyDOI
10.1089/hum.2010.131PubMed ID
20626322Type
ArticleLanguage
enISSN
1557-7422ae974a485f413a2113503eed53cd6c53
10.1089/hum.2010.131
Scopus Count
Collections
Related articles
- Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune response.
- Authors: Hombach A, Hombach AA, Abken H
- Issue date: 2010 Oct
- Chimeric antigen receptors for T-cell based therapy.
- Authors: Cheadle EJ, Sheard V, Hombach AA, Chmielewski M, Riet T, Berrevoets C, Schooten E, Lamers C, Abken H, Debets R, Gilham DE
- Issue date: 2012
- CAR T cells transform to trucks: chimeric antigen receptor-redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer.
- Authors: Chmielewski M, Abken H
- Issue date: 2012 Aug
- [Novel therapy for malignant lymphoma: adoptive immuno-gene therapy using chimeric antigen receptor(CAR)-expressing T lymphocytes].
- Authors: Ozawa K
- Issue date: 2014 Mar
- Adoptive cancer immunotherapy using genetically engineered designer T-cells: First steps into the clinic.
- Authors: Eshhar Z
- Issue date: 2010 Feb